References
1.
Knipschild P: Systematic reviews. Some examples. BMJ 1994;309:719–721.
2.
Chalmers I, Altman DG: Systematic Reviews. London, BMJ Publishing, 1995.
3.
Antman EM, Lau J, Kupelnick B, Mosteller F, Chalmers TC: A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. JAMA 1992;268:240–248.
4.
Tarrier N: Cognitive-behaviour therapy for schizophrenia – a review of development, evidence and implementation. Psychother Psychosom 2005;74:136–144.
5.
Tarrier N, Wykes T: Is there evidence that cognitive behaviour therapy is an effective treatment for schizophrenia? A cautious or cautionary tale? Behav Res Ther 2004;42:1377–1401.
6.
Pilling S, Bebbington P, Kuipers E, Garety P, Geddes J, Orbach G, Morgan C: Psychological treatments in schizophrenia. I. Meta-analysis of family intervention and cognitive behaviour therapy. Psychol Med 2002;32:763–782.
7.
Jones C, Cormac I, Silveira DM, Campbell C: Cognitive behaviour therapy for schizophrenia. Cochrane Database Syst Rev 2004;CD000524.
8.
Gould RA, Mueser KT, Bolton E, Mays V, Goff D: Cognitive therapy for psychosis in schizophrenia: An effect size analysis. Schizophr Res 2001;48:335–342.
9.
Rector NA, Beck AT: Cognitive behavioral therapy for schizophrenia: An empirical review. J Nerv Ment Dis 2001;189:278–287.
10.
Sensky T: The utility of systematic reviews: The case of psychological debriefing after trauma. Psychother Psychosom 2003;72:171–175.
11.
Mulrow CD: Rationale for systematic reviews. BMJ 1994;309:597–599.
12.
Rosenthal R, DiMatteo MR: Meta-analysis: Recent developments in quantitative methods for literature reviews. Annu Rev Psychol 2001;52:59–82.
13.
Thompson SG: Why sources of heterogeneity in meta-analysis should be investigated. BMJ 1994;309:1351–1355.
14.
Higgins JP, Thompson SG, Deeks JJ, Altman DG: Measuring inconsistency in meta-analyses. BMJ 2003;327:557–560.
15.
Bulpitt CJ: Subgroup analysis. Lancet 1988;ii:31–34.
16.
Smith GD, Egger M, Phillips AN: Meta-analysis: Beyond the grand mean? BMJ 1997;1997:1610.
17.
Montori VM, Jaeschke R, Schunemann HJ, Bhandari M, Brozek JL, Devereaux PJ, Guyatt GH: Users’ guide to detecting misleading claims in clinical research reports. BMJ 2004;329:1093–1096.
18.
Carpenter WTJ, Strauss JS: The prediction of outcome in schizophrenia. IV. Eleven-year follow-up of the Washington IPSS cohort. J Nerv Ment Dis 1991;179:517–525.
19.
Guyatt GH, Sackett DL, Cook DL: Users’ guides to the medical literature. II. How to use an article about therapy or prevention. B. What were the results and will they help me in caring for my patients? JAMA 1994;271:59–63.
20.
Scott J, Sensky T: Methodological aspects of randomized controlled trials of psychotherapy in primary care. Psychol Med 2003;33:191–196.
21.
Sharpe L, Ryan B, Allard S, Sensky T: Testing for the integrity of blinding in clinical trials: How valid are forced choice paradigms? Psychother Psychosom 2003;72:128–131.
22.
Salkovskis PM: Empirically grounded clinical interventions: Cognitive-behavioural therapy progresses through a multi-dimensional approach to clinical science. Behav Cogn Psychother 2002;30:3–9.
23.
Startup M, Jackson M, Pearce E: Assessing therapist adherence to cognitive-behaviour therapy for psychosis. Behav Cogn Psychother 2002;30:329–339.
24.
Schwartz D, Lellouch J: Explanatory and pragmatic attitudes in therapeutic trials. J Chron Dis 1967;20:637–648.
25.
Meyer B, Pilkonis PA, Krupnick JL, Egan MK, Simmens SJ, Sotsky SM: Treatment expectancies, patient alliance, and outcome: Further analyses from the National Institute of Mental Health Treatment of Depression Collaborative Research Program. J Consult Clin Psychol 2002;70:1051–1055.
26.
Malterud K: The art and science of clinical knowledge: Evidence beyond measures and numbers. Lancet 2001;358:397–400.
27.
Teasdale JD, Segal ZV, Williams JM, Ridgeway VA, Soulsby JM, Lau MA: Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. J Consult Clin Psychol 2000;68:615–623.
28.
Fava GA: Well-being therapy: Conceptual and technical issues. Psychother Psychosom 1999;68:171–179.
29.
McCulloch P, Taylor I, Sasako M, Lovett B, Griffin D: Randomised trials in surgery: Problems and possible solutions. BMJ 2002;324:1448–1451.
30.
Olsen O, Middleton P, Ezzo J, Gotzsche PC, Hadhazy V, Herxheimer A, Kleijnen J, McIntosh H: Quality of Cochrane reviews: Assessment of sample from 1998. BMJ 2001;323:829–832.
31.
Messerli FH: Are calcium antagonists safe? Lancet 1995;346:767–768.
32.
Sensky T: Knowledge management. Adv Psychiatr Treat 2002;8:387–395.
33.
Guyatt G, Cook D, Haynes B: Evidence based medicine has come a long way. BMJ 2004;329:990–991.
© 2005 S. Karger AG, Basel
2005
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the...
© 2005 S. Karger AG, Basel
2005
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
